Prolonged paradoxical reaction to anti-tuberculous treatment after discontinuation of TNF-alpha- blocker therapy with adalimumab. Rare clinical documentation

por Falkenstern-Ge, Roger Fei, Husemann, Kim, Kohlhäufl, Martin
Publicado 2014

A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy

por Mönch, Dina, Bode-Erdmann, Sabine, Kalla, Jörg, Sträter, Jörn, Schwänen, Carsten, Falkenstern-Ge, Roger, Klumpp, Siegfried, Friedel, Godehard, Ott, German, Kalla, Claudia
Publicado 2018